* Si quieres que hagamos difusión de tus artículos escríbenos a documentacion.iacs@aragon.es
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
Isla D, Lopez-Brea M, Espinosa M, Arrabal N, Pérez-Parente D, Carcedo D, Bernabé-Caro R.
Cost Eff Resour Alloc. 2023 Jan 16;21(1):6. doi: 10.1186/s12962-023-00417-z.
Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
Bea AM, Cenarro A, Marco-Benedí V, Laclaustra M, Martín C, Ibarretxe D, Pintó X, Arrobas T, Viñals C, Civeira F, Olmos S.
Clin Chem. 2023 Jan 16:hvac213. doi: 10.1093/clinchem/hvac213
Patient care pathways for pregnancy in rare and complex rheumatic diseases: results from an international survey.
Tani C, Zucchi D, Bellis E, Talabi MB, Frise C, de Jesús GR, Koksvik HS, Lledó GM, Mekinian A, Marinello D, Palla I, Mehta P, Comet LS, Shaimaa S, Smeele HTW, Talarico R, Brucato A, Khamashta M, Shoenfeld Y, Tincani A, Mosca M.
J Rheumatol. 2023 Jan 15:jrheum.220773. doi: 10.3899/jrheum.220773
Comparative clinical and biomechanical study of different types of osteosynthesis in the treatment of distal femur fractures.
Redondo-Trasobares B, Sarasa-Roca M, Rosell-Pradas J, Tapie JC, Gracia-Villa L, Albareda-Albareda J.
Rev Esp Cir Ortop Traumatol. 2023 Jan 14:S1888-4415(23)00003-6. doi: 10.1016/j.recot.2023.01.003
Rickettsia sibirica infection.
Lasierra Lavilla I, Caballero Castro JP, Zabala López SI.
Med Clin (Barc). 2023 Jan 14:S0025-7753(22)00669-8. doi: 10.1016/j.medcli.2022.12.012
[Decreased muscle mass in type-2 diabetes. A hidden comorbidity to consider].
de Luis Román D, Garrachón Vallo F, Carretero Gómez J, López Gómez JJ, Tarazona Santabalbina FJ, Guzmán Rolo G, García Almeida JM, Sanz Paris A.
Nutr Hosp. 2023 Jan 11. doi: 10.20960/nh.04468
Cross-sectional and longitudinal associations between family meals frequency and children’s overweight/obesity in families at high risk of type 2 diabetes: The Feel4Diabetes-study.
Mahmood L, Gonzalez-Gil EM, Makrilakis K, Liatis S, Schwarz P, Herrmann S, Willems R, Cardon G, Latomme J, Rurik I, Radó S, Iotova V, Usheva N, Tankova T, Karaglani E, Manios Y, Moreno LA; Feel4Diabetes-Study Group.
Pediatr Obes. 2023 Jan 11:e13000. doi: 10.1111/ijpo.13000
Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry.
Raposeiras-Roubín S, Núñez-Gil IJ, Jamhour K, Abu-Assi E, Conty DA, Vedia O, Almendro-Delia M, Sionis A, Martin-Garcia AC, Corbí-Pascual M, Martínez-Sellés M, Uribarri A, Guillén M, María García Acuña J, País JL, Blanco E, Linares Vicente JA, Flecha ASG, Andrés M, Pérez-Castellanos A, Alonso J, Rosselló X, Romo AI, Feltes G; RETAKO investigators.
Rev Port Cardiol. 2023 Jan 9:S0870-2551(23)00045-8. doi: 10.1016/j.repc.2022.02.010
Ethical consultancy. Towards an applicable and sustainable Spanish model.
Altisent R, Fins JJ.
Rev Clin Esp (Barc). 2023 Jan;223(1):58-59. doi: 10.1016/j.rceng.2022.11.002
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
Villarroel PG, Padró JG, Marquina G, Jáñez NM, González EE, Antón A, Sánchez MB, Cáceres AR, López-López R, Cornejo RE, García PB, Fabregat RM, Fernández BC, Bermudo CL, Camps C.
Future Oncol. 2022 Nov;18(35):3913-3927. doi: 10.2217/fon-2022-0758.